Search company, investor...

ElexoPharm

elexopharm.de

Founded Year

2005

Stage

Grant | Alive

Total Raised

$2.7M

Last Raised

$2.7M | 11 yrs ago

About ElexoPharm

ElexoPharm is a German biotech company, founded as a spin-off of the Department of Pharmaceutical and Medicinal Chemistry of Saarland University. ElexoPharm is focused on the preclinical discovery and optimization of drugs for human diseases, which are currently not or insufficiently treatable with existing drugs.

Headquarters Location

Im Stadtwald Geb. A1

66123,

Germany

Missing: ElexoPharm's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: ElexoPharm's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

ElexoPharm Patents

ElexoPharm has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/5/2015

2/6/2018

Transcription factors, EC 1.1.1, Intracellular receptors

Grant

Application Date

1/5/2015

Grant Date

2/6/2018

Title

Related Topics

Transcription factors, EC 1.1.1, Intracellular receptors

Status

Grant

Latest ElexoPharm News

Elexopharm Enters Into Cardiovascular Collaboration With Merck & Co., Inc

Mar 11, 2021

Monday, 17 May 2010 12:00 Hits: 3189 Saarbruecken, Germany, May 17, 2010 / b3c newswire / - ElexoPharm GmbH announced today a collaboration and exclusive worldwide license agreement with Merck & Co., Inc. Whitehouse Station, New Jersey USA (also known as MSD outside of the US and Canada) through an affiliate to develop and commercialize novel candidates targeting aldosterone synthase for the potential treatment of cardiovascular disease. Under the terms of the agreement, Merck will pay ElexoPharm an upfront payment of €1.5 million. In addition ElexoPharm is eligible to receive up to an additional €32.3 million if specific development, regulatory and commercial milestones are achieved for a candidate and royalties on net sales of any products resulting from the collaboration. Merck is responsible for development, regulatory filings, manufacturing and commercialization activities. “This agreement marks a major milestone in ElexoPharm’s relatively recent company history," said Axel Koch, Managing Director of ElexoPharm GmbH, "We are delighted to have a partner such as Merck.”   "This agreement with ElexoPharm underscores Merck's ongoing commitment to developing breakthrough cardiovascular medicines," said Andrew Plump, M.D., vice president, cardiovascular disease discovery research, Merck Research Laboratories. ElexoPharm is a German biotech company located in Saarbruecken founded as a spin-off from the Department of Pharmaceutical and Medicinal Chemistry of Saarland University headed by Professor Rolf Hartmann. ElexoPharm is focused on preclinical medicinal chemistry research concerning the design and development of new drugs, using novel therapeutic approaches for human diseases, which are currently not or insufficiently treatable with existing drugs.

ElexoPharm Frequently Asked Questions (FAQ)

  • When was ElexoPharm founded?

    ElexoPharm was founded in 2005.

  • What is ElexoPharm's latest funding round?

    ElexoPharm's latest funding round is Grant.

  • How much did ElexoPharm raise?

    ElexoPharm raised a total of $2.7M.

  • Who are the investors of ElexoPharm?

    Investors of ElexoPharm include Bundesministerium fur Bildung und Forschung, Saarland University and Saarlaendische Wagnisfinanzierungsgesellschaft mbH.

  • Who are ElexoPharm's competitors?

    Competitors of ElexoPharm include United BioSource, Biocrates Life Sciences, Pharmaron, Sai Life Sciences, WuXi AppTec and 12 more.

Compare ElexoPharm to Competitors

Sai Life Sciences Logo
Sai Life Sciences

Sai Life Sciences offers their clients a wide range of integrated drug discovery, development and formulation services, with core expertise founded in synthetic, medicinal and process chemistry and further augmented by a suite of preclinical support services including DMPK, toxicology and formulation that are continually expanding to meet clients' needs.

P
Pacific Data Designs

ClinOps, LLC, is a focused contract research organization serving the Biotechnology, Pharmaceutical and Medical Device industries and specializes in data management, SAS/statistical analysis services, and investigatorinitiated study management. The company are committed to being a bestinclass partner to the company's clients by using the company's unparalleled core competencies to advance and accelerate their therapeutic clinical development initiatives.

R
Renovo Research

Renovo Research is a contract research lab that specializes in crystal form discovery for the pharmaceutical industry.

I
Informatics Outsourcing

Informatics Outsourcing, an analytics and research company based in Chennai, India, aims to provide expert services and cater to the outsourcing needs of Pharmaceutical and Biotech clients around the globe. The company have carved out a niche for ourselves on domains in the Pharma and Biotech industries that require outsourcing.nThe company provide the company's services in Clinical Data Management, Computational Chemistry, Data Handling, Software Engineering and Research Services.

B
BioMedical Research Associates

BMRA aims to provide contract research services for medical device manufacturers, R&D groups, and other organizations requiring large or small animal models for device/drug applications and evaluations

C
Clinical Trials of the Americas

The company provide clinical research services to area physicians in a range of therapeutic specialties and contract with pharmaceutical companies and contract research organizations (CROs) to conduct in-patient clinical research. The company have successfully conducted more than 500 Phase I, II, III, and IV clinical trials and utilize the Clinasyst Software  System for trial management with a database of greater than 40,000 subjects.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.